# VTE Prophylaxis

**Division of Acute Care Surgery**  
*Revised: January 2025*

---

## I. Purpose

Prevent pulmonary embolism (PE) and deep vein thrombosis (DVT) in trauma patients.

---

## II. Risk Factors

**High Risk**  
- Age > 60  
- GCS < 9 > 4 hrs  
- PMH of VTE  
- Lower extremity fracture  
- Multiple spinal fractures  
- Pregnancy  

**Very High Risk**  
- SCI with paralysis  
- ≥2 complex lower extremity fractures  
- Major pelvic fracture  
- ≥3 long bone fractures (≥1 in LE)  
- Age ≥ 75 + any high-risk factor  
- Abdominal/LE venous repair/ligation  

---

## III. VTE Prophylaxis Protocol

### A. All Trauma Patients
- Apply bilateral SCDs unless contraindicated

### B. Enoxaparin Dosing (q12h)

| Weight (kg) | Dose         | Anti-Xa Required |
|-------------|--------------|------------------|
| < 50        | 30 mg        | Yes              |
| 50–89       | 30 mg        | No               |
| 90–129      | 40 mg        | Yes              |
| 130–179     | 60 mg        | Yes              |
| ≥ 180       | 80 mg        | Yes              |

### C. Other Considerations
- BMI ≥ 40 → SQ heparin 7500 units q8h if no epidural or block
- Do not hold for elevated INR due to liver dysfunction
- Hold only for spine/neurosurgical OR or if attending requests

---

## IV. Exceptions

### A. TBI – Based on Brain Injury Guidelines (BIG)

| BIG Category | Description                             | Start VTE ppx |
|--------------|-----------------------------------------|---------------|
| BIG 1        | Minor bleeds, stable repeat CTH         | 24 hrs        |
| BIG 2        | Moderate bleeds                         | 48 hrs        |
| BIG 3        | Severe bleeds, worsening on repeat CTH  | 72 hrs        |

- MMA embolization → hold morning of procedure  
- Intraspinal hematoma → start within 48 hrs  
- Spine surgery → hold AM of surgery, resume 24 hrs post-op  
- Enoxaparin preferred with ICP monitor/EVD  

---

## V. Epidural/Block/Lumbar Drain

- Hold enoxaparin 12 hrs pre-placement and 4 hrs post-removal  
- Use heparin 5000 units q8h + SCDs while catheter is in place  

---

## VI. Renal Impairment

- CrCl < 30 or significant ↑ in SCr → use SQ heparin  
- RRT → heparin preferred  

---

## VII. Anti-Xa Monitoring

- Indications: weight <50 or ≥90 kg; all very high-risk patients  
- Draw peak 4 hrs after 3rd enoxaparin dose  
- Goal: 0.2–0.4 IU/mL  

**Dose adjustment:**

- Below goal → ↑ to next syringe size  
- Above goal:
  - ↓ to next size or 30–40 mg q24h  
  - If still high → switch to heparin q8h  
- Non-standard doses → monitor Anti-Xa weekly  
- If at goal on weight-based dosing → no further monitoring

---

## VIII. Surveillance

- **Very high-risk:** Duplex LE US 72 hrs post-admission, then weekly × 4 weeks  
- Then every 2 weeks thereafter

---

## IX. IVC Filter

Refer to [IVC Filter PMG](#)

### Consider prophylactic filter if:
- SCI with paralysis  
- IVC/iliac/femoral repair or ligation  
- Severe pelvic + LE long bone fracture  
- AIS head ≥3 + anticoagulation contraindication  
- Anticoag failure or complication

---

## X. Post-Discharge VTE Prophylaxis

### A. 30 Days:
- Very high-risk (e.g. SCI)  
- Operative LE fracture  
- Femoral head fracture  
- Non-ambulatory (>30 ft)

### B. 90 Days:
- Spinal cord injury

---

## XI. References

_Essential literature includes EAST PMG (2002), multiple trauma studies validating weight-based enoxaparin dosing, safety in TBI/spine patients, and recent AAST/ACS protocols for post-discharge prophylaxis._  
**Full citations available upon request.**

---

## XII. Authors

- **Bradley Dennis, MD**  
- **Jill Streams, MD**  
- **Jennifer Beavers, PharmD, BCPS**  
- **Jennifer Emerson, PharmD**  
- **Chelsea Tasaka, PharmD, BCCCP**
